Warsaw breakage syndrome

Warsaw breakage syndrome
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Microcephaly, growth retardation, intellectual disability, facial dysmorphism
Complications	N/A
Onset	Congenital
Duration	Lifelong
Types	N/A
Causes	Mutations in the DDX11 gene
Risks	N/A
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis	N/A
Prevention	N/A
Treatment	Supportive care
Medication	N/A
Prognosis	Variable
Frequency	Rare
Deaths	N/A

Warsaw breakage syndrome (WABS) is a rare autosomal recessive genetic disorder characterized by microcephaly, growth retardation, intellectual disability, and facial dysmorphism. It is caused by mutations in the DDX11 gene, which plays a crucial role in DNA replication and chromosome segregation.

Genetics

Warsaw breakage syndrome is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The DDX11 gene, located on chromosome 12, encodes a DNA helicase that is essential for the maintenance of genomic stability. Mutations in this gene lead to defects in DNA repair and chromosomal breakage, which are hallmarks of the syndrome.

Clinical Features

Individuals with Warsaw breakage syndrome typically present with:

• Microcephaly: A significantly smaller head size compared to peers, often present at birth.
• Growth retardation: Delayed growth and development, resulting in short stature.
• Intellectual disability: Ranging from mild to severe, affecting cognitive and adaptive functioning.
• Facial dysmorphism: Distinctive facial features that may include a broad nasal bridge, upslanting palpebral fissures, and a small jaw.

Diagnosis

Diagnosis of Warsaw breakage syndrome involves a combination of clinical evaluation and genetic testing. The presence of characteristic clinical features may prompt genetic testing to identify mutations in the DDX11 gene. Chromosomal breakage studies may also be conducted to assess the stability of chromosomes in affected individuals.

Management

There is currently no cure for Warsaw breakage syndrome, and management is primarily supportive. Treatment may include:

• Developmental therapy: To address intellectual and developmental delays.
• Growth monitoring: Regular assessment of growth parameters to manage growth retardation.
• Multidisciplinary care: Involving specialists such as geneticists, neurologists, and endocrinologists to address various aspects of the disorder.

Prognosis

The prognosis for individuals with Warsaw breakage syndrome varies depending on the severity of the symptoms and the presence of any complications. Early intervention and supportive care can improve quality of life and developmental outcomes.

Research Directions

Ongoing research aims to better understand the molecular mechanisms underlying Warsaw breakage syndrome and to explore potential therapeutic approaches. Studies are focused on the role of the DDX11 gene in DNA repair and chromosome stability, as well as the development of targeted therapies to address the genetic defects.

See Also

• DNA repair disorders
• Chromosomal instability syndromes

External Links

• [Genetic and Rare Diseases Information Center - Warsaw Breakage Syndrome](https://rarediseases.info.nih.gov/diseases/10754/warsaw-breakage-syndrome)